Oneness Biotech Co (LUX:ONEA) Long-Term Capital Lease Obligation : $12.23 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Oneness Biotech Co Long-Term Capital Lease Obligation?

Oneness Biotech Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $12.23 Mil.

Oneness Biotech Co's quarterly Long-Term Capital Lease Obligation declined from Jun. 2023 ($8.03 Mil) to Sep. 2023 ($7.59 Mil) but then increased from Sep. 2023 ($7.59 Mil) to Mar. 2024 ($12.23 Mil).

Oneness Biotech Co's annual Long-Term Capital Lease Obligation declined from Dec. 2020 ($9.92 Mil) to Dec. 2021 ($9.74 Mil) and declined from Dec. 2021 ($9.74 Mil) to Dec. 2022 ($8.16 Mil).

Oneness Biotech Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Oneness Biotech Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co Long-Term Capital Lease Obligation Chart

Oneness Biotech Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

10.00

9.92

9.74

8.16

Oneness Biotech Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															8.16	8.06	8.03	7.59	12.23

Oneness Biotech Co (LUX:ONEA) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Oneness Biotech Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Oneness Biotech Co (LUX:ONEA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (LUX:ONEA) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

4743:Taiwan

Address

No. 236, Section 4, Xinyi Road, 11th Floor, Daan District, Taipei, TWN, 106

Website

https://www.onenessbio.com.tw

Oneness Biotech Co Ltd is a Taiwan based biopharmaceutical company. The company develops healthcare drugs. Its products are used for chronic diabetic, dengue hemorrhagic fever, and Rheumatoid Arthritis. The company's operating segment includes New Drug Research and Development and Agricultural Products Cultivation. It generates maximum revenue from New Drug Research and Development segment.

Oneness Biotech Co (LUX:ONEA) Headlines

No Headlines